Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Premier Health of America Inc V.PHA

Premier Health of America Inc. is a Canada-based healthtech company. The Company is a specialized healthcare services company that provides a range of staffing and outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company operates through two segments: Per Diem and Travel Nurse. The Company’s Per diem segment includes staff who work on an as-needed basis, sometimes for multiple health care institutions and are typically assigned shifts at the last minute and paid directly tied to worked hours. Its Travel Nurse segment includes healthcare professionals who work in temporary positions, carrying out short- and medium-term assignments that require travel, especially in remote areas. Its services are provided through its LiPHe platform developed with the objective of optimizing and streamlining the business-to-customer relationship and product offering through the use of business process automation and business intelligence applications.


TSXV:PHA - Post by User

Post by CauseWhyNoton Jul 27, 2023 10:09am
79 Views
Post# 35559399

Stock price

Stock price

Still very little resistance! This will pop on closing of the deal. I sincerely doubt an equity raise at these level. Likely 80 cents or higher 

I suspect we get a double dose of positive news in august. 1) close deal, 2) financials show grow in current operations

just a kind reminder, the company they are acquiring is based on sept 2022 numbers.. I am optimistic there will significant growth YOY ...

post acquisition: 170-180 million in rev. 10% ebitda (adjusted due to fees related to acquisitions). 5 times ebitda = 85-90 million enterprise value. Less 40 million debt. 50-55million. Or 0.90-1.00... if they do show growth, a 7-9 ebitda is possible. (9X) or 153m enterprise value less debt = 113Million or $2 per share.

if someone were to buy them, we would probably get the 9-10 times ebitda. 

come on august! 

<< Previous
Bullboard Posts
Next >>